Skip to main content
. Author manuscript; available in PMC: 2021 Sep 1.
Published in final edited form as: Infect Dis Clin North Am. 2020 Sep;34(3):585–603. doi: 10.1016/j.idc.2020.06.012

Figure 2: Approach to the patient with opioid use disorder (OUD) during incarceration and prior to community reentry.

Figure 2:

During incarceration, patients with OUD should undergo a comprehensive evaluation. This evaluation should include: the assessment and management of psychiatric/medical comorbidities; infectious diseases screening and immunizations; medical treatment of OUD and chronic infections; and a plan for transition to ongoing care for OUD and its infectious complications in the community upon reentry. OUD = opioid use disorder; RODS = Rapid Opioid Dependence Screen;28 XR-NTX = extended-release naltrexone; HIV = human immunodeficiency virus; HBV = hepatitis B virus; HCV = hepatitis C virus; ARV = antiretroviral therapy for HIV; DAA = direct-acting antiviral therapy for viral hepatitis; LOS = Length of stay. †Patient navigation or follow-up in a transitions clinic, if available, may improve healthcare engagement.61,64 (Adapted from Masyukova MI., Hanna DB., Fox AD. HIV treatment outcomes among formerly incarcerated transitions clinic patients in a high prevalence setting. Health Justice 2018;6(1):16. Doi: 10.1186/s40352–018-0074–5; Cunningham WE., Weiss RE., Nakazono T., et al. Effectiveness of a Peer Navigation Intervention to Sustain Viral Suppression Among HIV-Positive Men and Transgender Women Released From Jail: The LINK LA Randomized Clinical Trial. JAMA Internal Medicine 2018;178(4):542; with permission.)